Form 8-K - Current report:
SEC Accession No. 0001104659-25-020404
Filing Date
2025-03-04
Accepted
2025-03-04 17:07:30
Documents
15
Period of Report
2025-03-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm258273d1_8k.htm   iXBRL 8-K 28023
2 EXHIBIT 99.1 tm258273d1_ex99-1.htm EX-99.1 238259
6 GRAPHIC tm258273d1_ex99-1img001.jpg GRAPHIC 5982
  Complete submission text file 0001104659-25-020404.txt   471537

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cyrx-20250304.xsd EX-101.SCH 3015
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cyrx-20250304_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cyrx-20250304_pre.xml EX-101.PRE 22359
17 EXTRACTED XBRL INSTANCE DOCUMENT tm258273d1_8k_htm.xml XML 3673
Mailing Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027
Business Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027 (949) 232-1900
Cryoport, Inc. (Filer) CIK: 0001124524 (see all company filings)

EIN.: 880313393 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34632 | Film No.: 25706093
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)